CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue:
Total net revenue	$ 88,694	$ 65,755	$ 246,318	$ 185,045
Operating expenses:
Research and development	1,010	0	1,569	0
General and administrative	3,254	4,962	8,413	12,324
Total operating expenses	4,264	4,962	9,982	12,324
Income from operations	84,430	60,793	236,336	172,721
Other income (expense), net	(13)	(115)	85	(122)
Interest income	41	1,624	1,501	4,002
Interest expense	(4,603)	(4,693)	(13,680)	(13,971)
Changes in fair values of equity investments	(29,368)	0	39,245	0
Income before income taxes	50,487	57,609	263,487	162,630
Income tax expense, net	8,866	10,558	44,689	29,499
Net income	41,621	47,051	218,798	133,131
Net income attributable to noncontrolling interest	13,403	7,242	48,299	21,792
Net income attributable to Innoviva stockholders	$ 28,218	$ 39,809	$ 170,499	$ 111,339
Basic net income per share attributable to Innoviva stockholders	$ 0.28	$ 0.39	$ 1.68	$ 1.10
Diluted net income per share attributable to Innoviva stockholders	$ 0.26	$ 0.36	$ 1.53	$ 1.01
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	101,358	101,191	101,306	101,134
Shares used to compute diluted net income per share	113,572	113,415	113,543	113,394
Royalty revenue from a related party
Revenue:
Total net revenue	$ 88,694	$ 65,755	$ 236,318	$ 185,045
Revenue from collaborative arrangements with a related party
Revenue:
Total net revenue	$ 0	$ 0	$ 10,000	$ 0